Adoption of remote and virtual trial tools is helping to ensure the safety of dermatology patients during the pandemic. IQVIA Biotech shares how incorporating patient-centric approaches in future dermatology trials can increase patient access and engagement. Live: Tuesday, Jul. 21, 2020 at 11am EDT On demand available after airing until Jul. 21, 2021. Register free
Dermatology patients are eager to participate in trials from their homes during the COVID-19 pandemic. Sponsors and investigators managing dermatology clinical trials have quickly embraced remote and virtual tools to keep patients safe and keep trials moving forward.
Join our webinar and learn how to incorporate virtual approaches into the design and delivery of dermatology trials – to lower overall study risks and increase patient engagement.
Our experts will share:
Speakers: Sonja VanWye, RN, MSN, Director of Dermatology Strategy, IQVIA Biotech
Christopher Varner, Virtual Trials Project Manager, IQVIA
Jeff Bagshaw, Vice President, Global Business Development, IQVIA Biotech
Time and date: Tuesday, Jul. 21, 2020 at 11am EDT
On demand available after airing until Jul. 21, 2021.